» Articles » PMID: 23071925

Developing Micro-/nanoparticulate Drug Delivery Systems Using "design of Experiments"

Overview
Specialty Chemistry
Date 2012 Oct 17
PMID 23071925
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Of late, micro and nanoparticluate drug delivery systems have been gaining immense importance primarily attributed to their improved drug release controlling and targeting efficiencies. Also, the small particle size and desirable surface charge associated with these delivery systems render them suitable for specific applications like lymphatic uptake, pulmonary uptake, tumor targeting, brain targeting, etc. For decades, micro and nanoparticulate systems have been prepared by the conventional "trial and error" approach of changing One Variable at a Time (OVAT). Using this methodology, the solution of a specific problematic formulation characteristic can certainly be achieved, but attainment of the true optimal composition is never guaranteed. Thus, the present manuscript provides an updated account of the systematic approach "Design of Experiments (DoE)" as applicable to formulation development of microparticles and nanostructured systems. Besides providing a bird's eye view of the various experimental designs and optimization techniques employed for DoE optimization of such systems, the present manuscript also presents a copilation of the major micro/nano-structuctred systems optimized through DoE till date. In a nutshell, the article will act both as a ready reckoner of DoE optimization of micro/nano drug delivery systems and a catalyst in providing an impetus to young pharmaceutical "nano & micro" researchers to venture into the rewarding field of systematic DoE optimization.

Citing Articles

Identification and Characterization of Critical Processing Parameters in the Fabrication of Double-Emulsion Poly(lactic-co-glycolic) Acid Microparticles.

Bentley E, Subick S, Pezzillo M, Balmert S, Herbert A, Little S Pharmaceutics. 2024; 16(6).

PMID: 38931917 PMC: 11207479. DOI: 10.3390/pharmaceutics16060796.


Recent Advances in Stem Cell Differentiation Control Using Drug Delivery Systems Based on Porous Functional Materials.

Eom Y, Park J, Kim T J Funct Biomater. 2023; 14(9).

PMID: 37754897 PMC: 10532449. DOI: 10.3390/jfb14090483.


Andrographolide nanophytosomes exhibit enhanced cellular delivery and pro-apoptotic activities in HepG2 liver cancer cells.

Neamatallah T, Malebari A, Alamoudi A, Nazreen S, Alam M, Bin-Melaih H Drug Deliv. 2023; 30(1):2174209.

PMID: 36762548 PMC: 9930834. DOI: 10.1080/10717544.2023.2174209.


Fabrication, Optimization, and Characterization of Antibacterial Electrospun Shellac Fibers Loaded with Extract.

Krongrawa W, Limmatvapirat S, Vollrath M, Kittakoop P, Saibua S, Limmatvapirat C Pharmaceutics. 2023; 15(1).

PMID: 36678752 PMC: 9861391. DOI: 10.3390/pharmaceutics15010123.


Merging Experimental Design and Nanotechnology for the Development of Optimized Simvastatin Spanlastics: A Promising Combined Strategy for Augmenting the Suppression of Various Human Cancer Cells.

Badr-Eldin S, Aldawsari H, Alhakamy N, Fahmy U, Ahmed O, Neamatallah T Pharmaceutics. 2022; 14(5).

PMID: 35631609 PMC: 9143367. DOI: 10.3390/pharmaceutics14051024.


References
1.
Dong X, Mattingly C, Tseng M, Cho M, Adams V, Mumper R . Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization. Eur J Pharm Biopharm. 2008; 72(1):9-17. PMC: 2663602. DOI: 10.1016/j.ejpb.2008.11.012. View

2.
Shur J, Nevell T, Shute J, Smith J . The spray drying of unfractionated heparin: optimization of the operating parameters. Drug Dev Ind Pharm. 2008; 34(6):559-68. DOI: 10.1080/03639040701657552. View

3.
Marlowe E, SHANGRAW R . Dissolution of sodium salicylate from tablet matrices prepared by wet granulation and direct compression. J Pharm Sci. 1967; 56(4):498-504. DOI: 10.1002/jps.2600560415. View

4.
Bhavsar M, Tiwari S, Amiji M . Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design. J Control Release. 2005; 110(2):422-430. DOI: 10.1016/j.jconrel.2005.11.001. View

5.
El-Gibaly I, Abdel-Ghaffar S . Effect of hexacosanol on the characteristics of novel sustained-release allopurinol solid lipospheres (SLS): factorial design application and product evaluation. Int J Pharm. 2005; 294(1-2):33-51. DOI: 10.1016/j.ijpharm.2004.12.027. View